Vertex Pharmaceuticals (VRTX) received a significant boost as Health Canada's approval of ALYFTREK marked a vital step in expanding cystic fibrosis treatment options. This approval and other successes ...

The NHS will offer a once-daily triple therapy for cystic fibrosis to hundreds more patients, including those with rare ...

In July 2025, Vertex Pharmaceuticals Incorporated conducted a study is to evaluate the pharmacokinetics, safety, tolerability ...

Vertex Pharmaceuticals has solidified its leadership in the cystic fibrosis (CF) market through strategic innovation and ...

Latest studies show Us pharma giant Vertex's new CF wonder pill Alyftrek has shown better results than their currently ...

Cystic fibrosis is an inherited condition that affects many body functions such as breathing, digestion and reproduction. The lifelong condition becomes more severe with age and the majority have ...

Coa charity event in Fermanagh raises £3,109 for Cystic Fibrosis, celebrating Hannah Harte’s 30th birthday with music and marathon.

NHS patients in England with cystic fibrosis will be among the first in Europe to access a new treatment for their condition, ...

Coa charity event in Fermanagh raises £3,109 for Cystic Fibrosis, celebrating Hannah Harte’s 30th birthday with music and ...

About a third of lung transplant patients with cystic fibrosis receive elexacaftor-tezacaftor-ivacaftor; use is higher among ...

In cystic fibrosis, thick mucus builds up in the lungs, making it difficult to breathe. This inherited disease, which is typically diagnosed by age 2, can also lead to frequent lung infections and ...

Cystic fibrosis is a multi-system genetic disorder affecting the lungs, pancreas, liver and intestine. It can have a significant impact on life expectancy and quality of life. The current median age ...